C4 Therapeutics Inc. (CCCC)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

4.22

-3.76%

After-hours Dec 13, 2024, 05:44 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	20.76M	31.10M	45.78M	33.20M	21.38M	19.36M
Cost of Revenue	117.71M	7.57M	2.91M	77.47M	47.66M	28.59M
Gross Profit	-96.95M	23.52M	42.88M	-44.27M	-26.28M	-9.23M
Operating Income	-139.03M	-129.53M	-82.13M	-60.45M	-35.45M	-16.39M
Interest Income	9.81M	3.58M	387.00K	393.00K	1.83M	685.00K
Pretax Income	-131.21M	-128.18M	-83.89M	-66.96M	-33.30M	-15.71M
Net Income	-132.49M	-126.50M	-86.04M	-66.33M	-34.10M	-15.71M
Selling & General & Admin	42.08M	42.79M	33.25M	15.20M	8.77M	7.16M
Research & Development	117.71M	117.84M	94.67M	78.44M	48.06M	28.59M
Other Expenses	-	-	-	-	325.00K	-7.00K
Operating Expenses	159.79M	160.63M	127.92M	93.64M	56.83M	35.75M
Interest Expense	1.37M	2.22M	2.15M	1.23M	-	-
Selling & Marketing Expenses	-	-	-	-	-	-
Cost & Expenses	159.79M	160.63M	127.92M	93.64M	56.83M	35.75M
Income Tax	1.28M	-1.68M	2.15M	-626.00K	804.00K	678.00K
Shares Outstanding (Basic)	49.64M	48.86M	46.04M	43.06M	42.99M	14.79M
Shares Outstanding (Diluted)	49.64M	48.86M	46.04M	43.06M	42.99M	42.09M
EPS (Basic)	-2.67	-2.59	-1.87	-1.54	-0.79	-1.06
EPS (Diluted)	-2.67	-2.59	-1.87	-1.54	-0.79	-1.06
EBITDA	-122.10M	-124.28M	-78.84M	-62.89M	-30.56M	-15.12M
Depreciation & Amortization	7.74M	7.57M	2.91M	2.84M	2.74M	3.57M